切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (04) : 388 -391. doi: 10.3877/cma.j.issn.1674-3946.2021.04.010

论著

肝细胞肝癌并肝静脉癌栓外科手术治疗远期随访评价
余伟华1,(), 范耀刚1, 王义刚1, 杨楷1, 栗粟1   
  1. 1. 617067 四川省攀枝花市中心医院肝胆外科
  • 收稿日期:2021-01-18 出版日期:2021-08-17
  • 通信作者: 余伟华

Long-term follow-up evaluation of surgical treatment of 30 cases of hepatocellular carcinoma with hepatic vein tumor thrombus

Weihua Yu1,(), Yaogang Fan1, Yigang Wang1, Kai Yang1, Su Li1   

  1. 1. Department of Hepatobiliary Surgery, Panzhihua Central Hospital, Sichuan 617067, China
  • Received:2021-01-18 Published:2021-08-17
  • Corresponding author: Weihua Yu
  • Supported by:
    Sichuan health and Family Planning Commission Project(16PJ218)
引用本文:

余伟华, 范耀刚, 王义刚, 杨楷, 栗粟. 肝细胞肝癌并肝静脉癌栓外科手术治疗远期随访评价[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(04): 388-391.

Weihua Yu, Yaogang Fan, Yigang Wang, Kai Yang, Su Li. Long-term follow-up evaluation of surgical treatment of 30 cases of hepatocellular carcinoma with hepatic vein tumor thrombus[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(04): 388-391.

目的

探究外科手术治疗肝细胞肝癌并肝静脉癌栓的远期疗效。

方法

回顾性分析2013年1月至2015年12月82例肝细胞肝癌并肝静脉癌栓患者的临床资料,按不同治疗方式将采用外科手术治疗的30例患者纳入手术组,将采用肝动脉灌注化疗栓塞术(TACE)治疗的52例患者纳入TACE组。采用SPSS23.0软件进行处理,GQOLI-74评分以(±s)表示,独立t检验;临床疗效采用秩和检验;并发症发生率及肿瘤复发率采用χ2检验;生存率采用Kaplan-meier法检验。P<0.05为差异有统计学意义。

结果

手术组治疗有效率(83.3%)及GQOLI-74评分高于TACE组(61.5%),差异有统计学意义(P<0.05);手术组1年、3年生存率高于TACE组,1年肿瘤复发率低于TACE组(P<0.05);两组并发症发生率、5年生存率及3年、5年肿瘤复发率比较,差异无统计学意义(P>0.05)。

结论

外科手术治疗肝细胞肝癌并肝静脉癌栓疗效良好,可提高患者远期预后,改善生活质量,且与TACE术后并发症风险均较低。

Objective

To analyze the long-term clinical outcome of surgical treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.

Methods

The clinical data of 82 patients with hepatocellular carcinoma with hepatic vein tumor thrombus from January 2013 to December 2015 were analyzed retrospectively. According to different treatment methods, 30 patients who underwent surgical treatment were enrolled into the operation group, 52 patients treated with hepatic artery infusion chemotherapy (TACE) were enrolled into the TACE group. SPSS23.0 software were used for processing the data, and the GQOLI-74 score was expressed as (±s), and was examined by using independent t test; the clinical outcome were examined by using rank sum test; the incidence of complications and the tumor recurrence rate were examined by χ2 test; while the survival rate was analyzed by using Kaplan-meier method. A P value of <0.05 was considered as statistically significant difference.

Results

The effective rate of treatment and GQOLI-74 score in the operation group were significantly higher than that in the TACE group (83.3% vs. 61.5%, P<0.05); the 1/3-year survival rate of operation group was higher than those of the TACE group, while the tumor recurrence rate was lower than that of the TACE group (P<0.05); There were no significant difference of complication rate, 5-year survival rate and 3/5-year recurrence rate between two groups (P>0.05).

Conclusion

Surgical treatment of hepatocellular carcinoma with hepatic vein tumor thrombus has a good effect, could improve the long-term prognosis of patients and the quality of life, while the risk of complications after TACE is relatively lower.

表1 82例肝细胞癌并HVTT患者不同治疗方式两组基线资料比较[(±s),例]
表2 82例肝细胞癌并HVTT患者不同治疗方式两组临床疗效比较(例)
表3 82例肝细胞癌并HVTT患者不同治疗方式两组并发症比较(例)
表4 82例肝细胞癌并HVTT患者不同治疗方式两组5年预后比较[例(%)]
表5 82例肝细胞癌并HVTT患者不同治疗方式两组GQOLI-74评分比较[(±s),分]
[1]
代柏树,杨振宇,杜锡林,等. 肝细胞癌合并门静脉癌栓的治疗进展[J]. 现代肿瘤医学,2018,26(10):1619-1623.
[2]
陈庆录,张冠平. TACE联合索拉非尼治疗肝癌合并门静脉癌栓的临床疗效及安全性[J]. 肝脏,2019,24(5):573-576.
[3]
吴晓峰,李相成,王科,等. 肝细胞癌伴下腔静脉癌栓的外科治疗[J]. 肝胆外科杂志,2017,25(1):72-73.
[4]
刘海亮,严茂林,白燕南,等. 手术治疗肝癌伴肝静脉癌栓的疗效分析[J]. 中华普通外科杂志,2019,34(8):652-655.
[5]
中国医师协会肝癌专业委员会. 肝细胞癌合并肝静脉或下腔静脉癌栓多学科诊治中国专家共识(2019版)[J]. 中国实用外科杂志,2020,40(1):17-22.
[6]
陈孝平,张万广. 肝癌切除技术创新与发展[J/CD]. 中华普外科手术学杂志(电子版),2017,11(5):361-363.
[7]
张福鑫,郑扬,涂攀. 完全腹腔镜术治疗开腹术后复发性肝细胞肝癌的疗效、安全性及预后分析[J/CD]. 中华普外科手术学杂志(电子版),2019,13(3):244-246.
[8]
张龙辉,王东,陈彧,等. 原发性肝癌合并右心房和下腔静脉癌栓的手术治疗[J]. 中华消化外科杂志,2017,16(1):90-94.
[9]
Takeda K, Tsurumaru Y, Yamamoto Y, et al. Treatment of hepatocellular carcinoma with hepatic vein tumor thrombosis protruding into the inferior vena cava by conversion surgery following chemotherapy with regorafenib: a case report[J]. Clin J Gastroenterol, 2020, 13(3): 428-433.
[10]
张世超,陈秦俊杰,李俊,等. TACE治疗对肝癌合并门静脉癌栓患者肝切除术后远期生存的影响[J]. 肝胆外科杂志,2018,26(2):89-93.
[11]
王毅,杨振华,柏尚柱,等. 手术切除与介入治疗巴塞罗那C期肝癌伴门静脉癌栓患者预后比较[J]. 局解手术学杂志,2017,26(7):509-513.
[12]
陈亚进,商昌珍,罗旋,等. 复发性肝癌合并门静脉癌栓的多学科综合治疗[J]. 中华消化外科杂志,2017,16(4):430-432.
[13]
钟腾猛,黄俊玲,岑炳奎. 外科手术治疗肝细胞癌伴肝静脉癌栓的疗效及随访评价[J]. 内蒙古医科大学学报,2020,42(5):509-512.
[14]
Ibrahim C, Parra N, Macedo FI, et al. Is hepatic resection better than transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis[J]. J Gastrointest Oncol, 2019, 10(6): 1064-1072.
[15]
余孝俊,刘子美,赵红川,等. 巨大肝癌伴门静脉癌栓的外科治疗[J]. 肝胆外科杂志,2020,28(4):252-255,307.
[1] 汪洪斌, 张红霞, 何文, 杜丽娟, 程令刚, 张雨康, 张萌. 低级别阑尾黏液性肿瘤与阑尾黏液腺癌超声及超声造影特征分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 865-871.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[8] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[9] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[10] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[11] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[12] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[13] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[14] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[15] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
阅读次数
全文


摘要